Isolation and Purification of a New Bacillus Subtilis Strain from Deer Dung with Anti-microbial and Anti-cancer Activities

Abstract

Objective

Bacillus strains are well known for their natural bioactive products that have antimicrobial and/or anti-cancer activities. Many of Bacillus’ structurally unique metabolites can combat human diseases, including cancers. However, because Bacillus’ metabolites are so abundant, few have been studied extensively enough to fully characterize their chemical constitutions and biological functions.

Methods

In this study, we focused on the isolation and purification of a new Bacillus strain, and determined the effects of its metabolites on bacteria and cancer cells. Our study focused on a new strain of Bacillus isolated from deer dung. Based on BLAST results, this isolate belongs to Bacillus subtilis, and therefore we named the strain Bacillus subtilis NC16. Congo red assay was used to test the cellulase activity. The inhibition zone was measured to test the antimicrobial activity. CCK-8, wound healing and flow cytometry were used to test the anti-cancer activity.

Results

Metabolites from Bacillus subtilis NC16 have both antimicrobial and anti-cancer activities. They can both suppress the growth of Trichoderma vride and Staphylococcus aureus, and inhibit the proliferation and promote the apoptosis of non-small cell lung cancer cell lines.

Conclusion

Our results suggest that Bacillus subtilis NC16 can not only degrade cellulose, but its metabolites may be sources of antibiotics and anti-cancer drugs.

Keywords

Bacillus subtilis / metabolites / non-small cell lung cancer / antibiotics / anti-cancer

References

[1] RevathiK, ChandrasekaranR, ThanigaivelA, et al.. Effects of Bacillus subtilis metabolites on larval Aedes aegypti L. Pestic Biochem Physiol, 2013, 107(3): 369-376

[2] ChakrabortyK, ThilakanB, RaolaVK. Polyketide family of novel antibacterial 7-O-methyl-5′-hydroxy-3′-heptenoate-macrolactin from seaweed-associated Bacillus subtilis MTCC 10403. J Agric Food Chem, 2014, 62(50): 12194-12208

[3] KabischJ, PratzkaI, MeyerH, et al.. Metabolic engineering of Bacillus subtilis for growth on overflow metabolites. Microb Cell Fact, 2013, 12: 72

[4] SinghNK, KaurC, KumarN, et al.. Bacillus aequororis sp. nov., isolated from marine sediment. Curr Microbiol, 2014, 69(5): 758-762

[5] IsmailS, DadrasniaA. Biotechnological potential of Bacillus salmalaya 139SI: a novel strain for remediating water polluted with crude oil waste. PLoS One, 2015, 10(4): e0120931

[6] HuangXF, ZhouD, GuoJ, et al.. Bacillus spp. from rainforest soil promote plant growth under limited nitrogen conditions. J Appl Microbiol, 2015, 118(3): 672-684

[7] BorrissR, DanchinA, HarwoodCR, et al.. Bacillus subtilis, the model Gram-positive bacterium: 20 years of annotation refinement. Microb Biotechnol, 2018, 11(1): 3-17

[8] ChenN, JinM, QuHM, et al.. Isolation and characterization of Bacillus sp. producing broad-spectrum antibiotics against human and plant pathogenic fungi. J Microbiol Biotechnol, 2012, 22(2): 256-263

[9] TorresMJ, PetroselliG, DazM, et al.. Bacillus subtilis subsp. subtilis CBMDC3f with antimicrobial activity against Gram-positive foodborne pathogenic bacteria: UV-MALDI-TOF MS analysis of its bioactive compounds. World J Microbiol Biotechnol, 2015, 31(6): 929-940

[10] CuiF, LinJ, LiY, et al.. Bacillus-shape design of polymer based drug delivery systems with janus-faced function for synergistic targeted drug delivery and more effective cancer therapy. Mol Pharm, 2015, 12(4): 1318-1327

[11] HassanMN, OsbornAM, HafeezFY. Molecular and biochemical characterization of surfactin producing Bacillus species antagonistic to Colletotrichum falcatum Went causing sugarcane red rot. Afr J Microbiol Res, 2010, 4(20): 2137-2142

[12] LarsenJE, MinnaJD. Molecular biology of lung cancer: clinical implications. Clin Chest Med, 2011, 32(4): 703-740

[13] FarhatFS, HouhouW. Targeted therapies in non-small cell lung carcinoma: what have we achieved so far?. Ther Adv Med Oncol, 2013, 5(4): 249-270

[14] SiegelRL, MillerKD, JemalA. Cancer Statistics, 2017. CA Cancer J Clin, 2017, 67(1): 7-30

[15] NihorimbereV, OngenaM, CawoyH, et al.. Beneficial effects of Bacillus subtilis on field-grown tomato in Burundi: reduction of local Fusarium disease and growth promotion. Afr J Microbiol Res, 2010, 4(11): 1135-1142

[16] YaseenY, GancelF, BechetM, et al.. Study of the correlation between fengycin promoter expression and its production by Bacillus subtilis under different culture conditions and the impact on surfactin production. Arch Microbiol, 2017, 199(10): 1371-1382

[17] DuarteC, GudinaEJ, LimaCF, et al.. Effects of biosurfactants on the viability and proliferation of human breast cancer cells. AMB Express, 2014, 4: 40

[18] ParkSY, KimJH, LeeYJ, et al.. Surfactin suppresses TPA-induced breast cancer cell invasion through the inhibition of MMP-9 expression. Int J Oncol, 2013, 42(1): 287-296

[19] WuYS, NgaiSC, GohBH, et al.. Anticancer Activities of Surfactin and Potential Application of Nanotechnology Assisted Surfactin Delivery. Front Pharmacol, 2017, 8: 761

[20] NguyenVA, HuynhHA, HoangTV, et al.. Killed Bacillus subtilis spores expressing streptavidin: a novel carrier of drugs to target cancer cells. J Drug Target, 2013, 21(6): 528-541

[21] GreenDJ, FrayoSL, LinY, et al.. Comparative Analysis of Bispecific Antibody and Streptavidin-Targeted Radioimmunotherapy for B-cell Cancers. Cancer Res, 2016, 76(22): 6669-6679

[22] YomogidaK, ChouY, PangJ, et al.. Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expression. Cytokine, 2012, 58(3): 431-436

[23] HajareSN, SubramanianM, GautamS, et al.. Induction of apoptosis in human cancer cells by a Bacillus lipopeptide bacillomycin D. Biochimie, 2013, 95(9): 1722-1731

[24] TabbeneO, KalaiL, Ben SlimeneI, et al.. Anti-candida effect of bacillomycin D-like lipopeptides from Bacillus subtilis B38. FEMS Microbiol Lett, 2011, 316(2): 108-114

[25] ZhouM, LiuF, YangX, et al.. Bacillibactin and Bacillomycin Analogues with Cytotoxicities against Human Cancer Cell Lines from Marine Bacillus sp. PKU-MA00093 and PKU-MA00092. Mar Drugs, 2018, 16(1): 22

[26] WestbrookAW, RenX, OhJ, et al.. Metabolic engineering to enhance heterologous production of hyaluronic acid in Bacillus subtilis. Metab Eng, 2018, 47: 401-413

[27] ScholzR, VaterJ, BudiharjoA, et al.. Amylocyclicin, a novel circular bacteriocin produced by Bacillus amyloliquefaciens FZB42. J Bacteriol, 2014, 196(10): 1842-1852

[28] MondolMA, ShinHJ, IslamMT. Diversity of secondary metabolites from marine Bacillus species: chemistry and biological activity. Mar Drugs, 2013, 11(8): 2846-2872

[29] YorozuyaW, NishiyamaN, ShindoT, et al.. Bacillus Calmette-Guerin may have clinical benefit for glandular or squamous differentiation in non-muscle invasive bladder cancer patients: retrospective multicenter study. Jpn J Clin Oncol, 2018, 48(7): 661-666

[30] ZhaoH, YanL, XuX, et al.. Potential of Bacillus subtilis lipopeptides in anti-cancer I: induction of apoptosis and paraptosis and inhibition of autophagy in K562 cells. AMB Express, 2018, 8(1): 78

[31] CordeiroRA, Weslley Caracas CedroE, Raquel Colares AndradeA, et al.. Inhibitory effect of a lipopeptide biosurfactant produced by Bacillus subtilis on planktonic and sessile cells of Trichosporon spp. Biofouling, 2018, 34(3): 309-319

[32] KimES, LeeHJ, BangWG, et al.. Functional characterization of a bacterial expansin from Bacillus subtilis for enhanced enzymatic hydrolysis of cellulose. Biotechnol Bioeng, 2009, 102(5): 1342-1353

[33] ZhangX, YaoQ, CaiZ, et al.. Isolation and identification of myxobacteria from saline-alkaline soils in Xinjiang, China. PLoS One, 2013, 8(8): e70466

[34] ZhouZ, LiuF, ZhangX, et al.. Cellulose-dependent expression and antibacterial characteristics of surfactin from Bacillus subtilis HH2 isolated from the giant panda. PLoS One, 2018, 13(1): e0191991

[35] WeissmanKJ, MullerR. Myxobacterial secondary metabolites: bioactivities and modes-of-action. Nat Prod Rep, 2010, 27(9): 1276-1295

[36] KasparF, NeubauerP, GimpelM. Bioactive Secondary Metabolites from Bacillus subtilis: A Comprehensive Review. J Nat Prod, 2019, 82(7): 2038-2053